Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
315,976,000
-
Total 13F shares
-
153,033,577
-
Share change
-
+3,371,747
-
Total reported value
-
$1,927,970,314
-
Put/Call ratio
-
4%
-
Price per share
-
$12.60
-
Number of holders
-
270
-
Value change
-
+$48,171,839
-
Number of buys
-
145
-
Number of sells
-
103
Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q4 2025
As of 31 Dec 2025,
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by
270 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
153,033,577 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., Rubric Capital Management LP, TPG GP A, LLC, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, MORGAN STANLEY, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and Assenagon Asset Management S.A..
This page lists
270
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.